test group:Camrelizumab

2 trials

Sponsors

Tianjin Medical University General Hospital, the First Affiliated Hospital of Zhengzhou University

Conditions

Tumors of the biliary systemlung cancer

Phase 2

Withdraw due to duplicate registration Single-arm, single-center, phase II clinical study of camrelizumab combined with chemotherapy for neoadjuvant + adjuvant therapy in resectable locally advanced non-small cell lung cancer

Active, not recruitingChiCTR2100049012

Tianjin Medical University General Hospitallung cancer

Start: 2021-07-20Updated: 2022-10-04

Phase 4

Real-world clinical study of camrelizumab in the treatment of advanced biliary system tumors

Active, not recruitingChiCTR2100049971

the First Affiliated Hospital of Zhengzhou UniversityTumors of the biliary system

Start: 2023-08-15Updated: 2022-04-19